≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

Ovarian dysfunction: androgen excess, drug-induced

Endpoint Browser

E4_ODANDRO_ADVERSE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ATC codes for adverse effects of Drugs — ANY
  • Hospital discharge: ICD-10 — E28.1#

1 out of 7 registries used, show all original rules.

7

4. Check minimum number of events

None

7

5. Include endpoints

None

7

6. Filter based on genotype QC (FinnGen only)

7

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
C
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
E28
Name in latin
Hypersecretio androgenorum

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (not available in FinRegistry).

-FinnGen-

Key figures

All Female Male
Number of individuals 7 7 -
Unadjusted period prevalence (%) 0.00 0.00 -
Median age at first event (years) 23.28 23.28 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
0
20
0.00
0.74
0.0
3.2
—
—
—
0
0
0
17
0.00
0.47
0.0
1.8
—
—
—
0
0
7
59
+∞
0.23
5.0
4.2
6.1
5.5
mmol/l
—
7
54
0
10
0.00
0.23
0.0
1.4
—
—
—
0
0
0
10
0.00
0.23
0.0
2.8
—
—
—
0
0
7
58
+∞
0.23
9.4
12.2
42.7
39.9
%
—
7
51
0
9
0.00
0.23
0.0
2.6
—
—
—
0
0
0
9
0.00
0.23
0.0
1.1
—
—
—
0
0
7
64
+∞
0.00
6.1
11.1
63.6
69.5
umol/l
—
7
64
7
62
+∞
0.00
8.1
12.7
331.9
330.1
g/l
—
7
62
0
5
0.00
0.00
0.0
2.6
—
4.7
—
0
5
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
1.7
—
0
5
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
7
65
+∞
0.00
6.3
10.8
—
—
—
0
0
0
6
0.00
0.00
0.0
11.8
—
9.8
—
0
6
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
364.7
—
0
7
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (not available in FinRegistry).

Relationships between endpoints

↥

Index endpoint: E4_ODANDRO_ADVERSE – Ovarian dysfunction: androgen excess, drug-induced

GWS hits: -

This endpoint is excluded (not available in FinRegistry).